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A Novel Spliceosome Containing U11, U12,
and U5 snRNPs Excises a Minor Class (AT±AC)
Intron In Vitro
Woan-Yuh Tarn and Joan A. Steitz the two exons for the final ligation step (Newman and
Norman, 1992; Sontheimer and Steitz, 1993).Department of Molecular Biophysics and Biochemistry
The vast majority of pre-mRNA introns obey the so-Howard Hughes Medical Institute
called GT±AG rule. Several lines of evidence indicateYale University School of Medicine
that the guanosine residues at the 59 and 39 termini ofNew Haven, Connecticut 06536
the intron form a non-Watson-Crick interaction essential
for the second step of splicing (Parker and Siliciano,
1993; Chanfreau et al., 1994; Scadden and Smith, 1995).
Summary Yet, substitution of A and C for the first and last intron
nucleotides, respectively, can suppress the splicing de-
A minor class of introns with noncanonical splice (AT± fect caused by either individual mutation. A minor class
AC) and branch site sequences exists in metazoan of introns that possess AT and AC at their 59 and 39
protein coding genes. We have established a HeLa cell ends, respectively, has recently been identified in both
in vitro system that accurately splices a pre-mRNA vertebrate and invertebrate genomes (Jackson, 1991;
substrate containing such an intron from the human Hall and Padgett, 1994). These minor class (AT±AC) in-
trons also exhibit longer, highly conserved but nonca-P120 gene. Splicing occurs via a lariat intermediate
nonical sequences at their 59 and 39 splice sites. The 59whose branch site A residue is predicted to bulge from
splice site consensus is /ATATCCTT and the 39 splicea duplex formed with the low abundance U12 small
site is CCAC/, while a third conserved intron elementnuclear ribonucleoprotein (snRNP), which we confirm
(TCCTTAAC) appears upstream of the 39 splice site. Soby psoralen cross-linking. Native gel electrophoresis
far, the AT±AC intron has been found in only four genes:reveals that U11, U12, and U5 snRNPs assemble onto
P120, characterized in several mammals including hu-theP120 pre-mRNA to formsplicing complexes. Inhibi-
man, codes for a proliferation-associated nucleolar pro-tion of P120 splicing by 29-O-methyl oligonucleotides
tein; CMP, in human and chicken, encodes a cartilagecomplementary to U12 or U5 demonstrates that U12
matrix protein; Rep-3 in mouse is a homolog of theand U5 snRNPs perform essential roles in the AT±AC
bacterial DNA mismatch repair protein MutS; and thespliceosome.
Drosophila prospero gene encodes a homeobox protein
involved in neurogenesis (Hall and Padgett, 1994, and
references therein). In each case, the pre-mRNA con-Introduction
tains other introns whose sequences conform to those
of major class introns. Neither the size nor the positionSplicing of nuclear pre-mRNAs occurs in the spliceo-
of the AT±AC intron within the host gene is conserved.some, a large and dynamic ribonucleoprotein complex.
Hall and Padgett (1994) recently proposed that the 59Spliceosome formation involves ordered assembly of
splice site and the 39 conserved element of AT±AC in-the U1, U2, U4/U6, and U5 small nuclear ribonucleopro-
trons might be recognized by the low abundance U11teins (snRNPs), together with a number of non-snRNP
and U12 snRNPs. The U11 and U12 snRNPs are mem-protein factors, onto the pre-mRNA. Biochemical and
bers of the Sm class, present in HeLa cells at aboutgenetic data from a variety of eukaryotic systems have
1/100 the level of the U1 snRNP (Montzka and Steitz,provided significant insight into snRNP±snRNP and
1988). In HeLa nuclear extracts, most U12 is found com-snRNP±substrate interactions within the spliceosome
plexed with U11, while a fraction of U11 (which is more(reviewed in Moore et al., 1993). To initiate spliceosome
abundant than U12) behaves as a mono-snRNP (Was-assembly, conserved sequences at the 59 splice site
sarman and Steitz, 1992). Although the secondary struc-and intron branch site direct association of U1 and U2
tures proposed for U11 and U12 RNAs resemble those
snRNPs, respectively, through base±pairing interac-
of U1 and U2 RNAs, respectively (Montzka and Steitz,
tions. The U5-U4/U6 tri-snRNP then joins the pre-splic-
1988), definitive functional assignments have been lack-
ing complex, resulting in base-pairing between the 59 ing for these snRNPs. U12 RNA homologs have been
end of U2 RNA and the 39 end of U6 RNA (reviewed characterized in twoother vertebrates where genes con-
in Nilsen, 1994). Conformational changes subsequently taining AT±AC introns have been found (Tarn et al.,
occur to build an intricate network of RNA±RNA interac- 1995); invariant sequences at the 59 end of U12 RNA,
tions, which juxtapose the intron splice sites. The asso- which include the predicted branch site±pairing region,
ciation of U1 and U4 snRNPs becomes destabilized, are consistent with the involvement of the U12 snRNP
allowing conserved sequences in U6 to interact with the in splicing of pre-mRNAs containing an AT±AC intron.
59 splice site and with regions of U2 RNA adjacent to Here, we describe an in vitro system that splices a
the intron branch site±U2 duplex (reviewed in Nilsen, pre-mRNA substrate containing an AT±AC intron de-
1994). Attack by the 29-hydroxyl group of the branch rived from the human P120 gene. Psoralen cross-linking
nucleotide (usually adenosine) on the 59 splice site initi- confirms the base-pairing interaction predicted by Hall
ates the splicing reaction, followed by a second transes- and Padgett (1994) between the branch site of the pre-
terification reaction which yields the ligated exons and mRNA substrate and U12 RNA. Probing theparticipation
the intron as a lariat structure.Meanwhile, a phylogeneti- of Sm snRNPs reveals that, in addition to the low abun-
cally invariant loop sequence of U5 RNA grips exon dance U11 and U12 snRNPs, the U5 snRNP, but surpris-
ingly not the U4 or U6 snRNP, becomes associated withnucleotides adjacent to the 59 splice site and aligns
Cell
802
end of U1 RNA (U11±14;data not shown). Concurrently, the
aberrantly spliced product diminished with increasing
amounts of the oligonucleotide U2b.
Sequences of bands labeled cryp and E1-E2 (Figure
1A) were determined by a reverse transcription±
polymerase chain reaction (RT±PCR) procedure. The se-
quence across the splice junction of E1±E2 was as ex-
pected. Since the 59 cleavage site was confirmed
subsequently (see below), the 39 splice site could be
deduced (Figure 1B).Sequencing across the splice junc-
tion of the aberrantly spliced product (cryp) revealed
that splicing occurred at sites within the P120 intron
(Figure 1B) in the absence of the oligonucleotide U2b.
The bona fide cryptic splice sites remain uncertain be-
cause splicing could occur one nucleotide upstream or
Figure 1. Activation of P120L Pre-mRNA Splicing by Debilitating U2 one or two nucleotides downstream of each indicated
snRNPs splice site (Figure 1B) and yield the same sequence.
(A) Splicing was carried out in HeLa nuclear extract in the absence Figure 1B indicates the most likely splice sites (59 /GC
(lane 1) or presence (lanes 2±5) of different amounts of the and 39 AG/), which areprobably recognized by the highly
29-O-methyl oligonucleotide U2b using uniformly labeled pre-mRNA
abundant snRNPs to assemble a major spliceosome(P120L) derived from the human P120 gene as substrate for 4 hr.
that competes with authentic splicing.The P120L precursor (pre-mRNA), the accurately spliced product
A pre-mRNA with a truncated 39 exon (P120) was next(E1-E2), and a cryptic splicing product (cryp) are indicated at the
right. The faster migrating splicing intermediates and excised intron constructed to optimize the sizes of splicing intermedi-
product of accurate splicing could also be observed (not shown ates and products and to remove nuclease-susceptible
here) but were usually buried under a smear of degraded fragments. regions in the 39 exon. Figure 2A shows splicing of the
Size markers were 32P-labeled pBR322 DNA digested with MspI,
P120 substrate in nuclear extract pretreated with thewith fragment lengths in nucleotides given on the left.
29-O-methyl oligonucleotide U2b. Splicing products, in-(B) The schematic shows the P120L precursor, the accurately
cluding the ligated exons and the lariat intron, accumu-spliced product and the sequences surrounding the authentic (arrow
with closed circle) and the cryptic (arrow with open circle) splice lated with incubation time; z6% of the pre-mRNA be-
sites, determined by RT±PCR. Other possible cryptic splice sites came spliced after 4 hr at 308C.
are pointed out in the text. Upper and lower cases represent exon Identification of splicing intermediates and products
and intron regions, respectively. Bold nucleotides denote conserved
was confirmed by debranching assays and by use of anelements (the 59 and 39 splice sites and the branch site) in AT±AC
oligonucleotide complementary to the predicted branchintrons.
site recognition region of U12 to block splicing (Figure
2B). When the P120 substrate was uniformly labeled,
the spliceosome assembled on the P120 minor class the lariat intron±exon 2 intermediate could not be distin-
intron. Our results suggest the existence of lower abun- guished from a 39-end-degraded substrate fragment
dance U4 and U6 snRNP analogs and raise many ques- (asterisks in Figures 2A and 2B, lanes 1 and 2), which
tions concerning the AT±AC spliceosome. was also visualized in U12-blocked extract (Figure 2B,
lane 2 and below). However, debranching of RNAs gen-
Results erated in a splicing reaction containing 39-end-labeled
P120 substrate (Figure 2B, lane 3) showed conversion
Splicing of the P120 Pre-mRNA Is Activated of the band indicated as lariat intron±exon 2 intermedi-
by Debilitating the U2 snRNP in HeLa ate to a faster migrating band of the expected size (199
Nuclear Extracts nt; Figure 2B, lane 5, and Figure 2C). Likewise, when
A splicing substrate (P120L) containing an AT±AC intron RNAs isolated from a reaction containing uniformly la-
was constructed from intron F and flanking exons of the beled P120 were subjected to the debranching assay,
human P120 gene (Figure 1). This particular minor class the lariat intron visualized in lane 1 (Figure 2B) was con-
intron was selected because of its small size (99 nt verted to a size of 99 nt (data not shown).
[nucleotides]); the other known mammalian AT±AC in- The branch nucleotide of the P120 intron was deter-
trons in the CMP and Rep-3 genes are 0.64 and 1.4 mined by primer extension on gel-purified lariat intron±
kb, respectively (Hall and Padgett, 1994 and references exon 2. Figure 2D shows specific blockage of extension
therein). When the P120L substrate was incubated in a at C191 using a primer complementary to a region of the
standard HeLa cell splicing extract, an aberrantly 39 exon (lane 6). This result suggests that the penultimate
spliced product (labeled cryp in Figure 1A, lane 1) was nucleotide, an A residue, of the conserved 39 element
generated apparently by the major spliceosome (see (Figure 1C) serves as the nucleophile in the first step of
below). Changes in pH or in the concentration of mono- the splicing reaction. Other minor terminated fragments
valent or divalent salts failed to activate usage of the probably derive from degraded substrate fragments or
AT±AC splice sites. However, appearance of the accu- aborted extension.
rately spliced product was induced by pretreatment of Extension on the lariat intron was also performed to
the nuclear extract with a 29-O-methyl oligonucleotide determine the exact 59 splice site utilized for intron exci-
complementary either to nt 27±49 (the branch site recog- sion in vitro. Using an intron primer, the major termina-
tion site was at A11, the predicted first nucleotide of thenition region) of U2 RNA (U2b; Figure 1A) or to the 59
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intron (Figure 2D, lane 12). The weaker upper band of
the doublet could result from nonspecific termination of
reverse transcription. These results confirm the accu-
racy of splicing and also indicate that the branch forms
between two A residues during splicing of the P120 pre-
mRNA.
Psoralen Cross-linking of U12 snRNA
to the Branch Site of the P120 Intron
To identify RNA±RNA interactions, the P120L substrate
was incubated under conditions that allow accurate
splicing for 15 min and then irradiated on ice with 365
nm light in the presence of AMT (49-aminomethyl-4,59,
8-trimethyl) psoralen (Wassarman, 1993). No specific
crosslinked products were detected in the absence of
nuclear extract (data not shown),whereas three retarded
bands appear in lane 1, Figure 3A. The snRNA species
contained in the crosslinked products were identified by
oligonucleotide-directed RNase H cleavage. The bands
labeled U12x1 and U12x2 each decreased to <20% their
original level (lane 2) when cleavage was induced by
an oligonucleotide complementary to nt 53±71 of U12
snRNA (lane 6), arguing that they both contain U12. The
intensity of the U12x1 cross-linked band was z3.5 fold
that of U12x2 in several experiments. The slower migrat-
ing product (labeled udx) was unchanged in the pres-
ence of oligonucleotides U279±98, U164±75, U1152±71, U1253±71
(lanes 3±6), or U1111±27 (data not shown), each of which
had previously been demonstrated to target its respec-
tive RNA (Montzka and Steitz, 1988; Tarn and Steitz,
1994).
Without addition of the 29-O-methyl oligonucleotide
U2b, U2 snRNA cross-linking to the P120 substrate was
detected in the same extract. With increasing amounts
of U2b, all three cross-links visualized in Figure 3A, lane
1, increased (data not shown). This suggests that the
highly abundant U2 snRNP competes directly with U12
for assembly onto the P120 pre-mRNA, activating cryp-
tic splice sites and preventing authentic AT±AC splicing.
Primer extension analyses were next performed to
determine the sites of psoralen cross-linking on both
U12 snRNA and P120L. When total RNA isolated from
the cross-linked splicing reaction was analyzed by
primer extension from an oligonucleotide complemen-
tary to the P120L 39 exon, several stops were detected
(Figure 3B, lane 11), suggesting abundant psoralen
monoadducts or intramolecular cross-linking. Use of the
Figure 2. Splicing of the P120 Pre-mRNA and Characterization of
same primer with either of the gel-purified U12 cross-the Lariat Splicing Intermediate
linked species detected a primary stop at U184, which
(A) Splicing of uniformly labeled P120 pre-mRNA was carried out in
a U2-blocked (1.2 mM U2b) nuclear extract at 308C for various times
as indicated at the top. Symbols on the right indicate the P120
precursor, splicing intermediates, and products. The aberrant mobil-
ity of linear RNA species containing the 59 exon in the 8% polyacryl- further in S100 extract for debranching (lanes 5 and 6). Note that
amide gel is probably due to its several stretches of purine-rich although the excised 59 exon and linearized intron±exon 2 intermedi-
sequence. The asterisk represents a degraded substrate fragment ate comigrate, only the former is visualized in lane 1 (nondeb-
comigrating with the lariat intron±exon 2 intermediate. The numbers ranched) and only the latter in lane 5 (39-end labeled).
at the left are the lengths of 32P-labeled fragments of MspI-digested (C) The schematic shows the pathway of P120 pre-mRNA splicing.
pBR322. (D) The lariat intron±exon 2 (IVS-E2) and the lariat intron (IVS) were
(B) Splicing of uniformly labeled (lanes 1 and 2) or 39-end labeled gel purified from a splicing reaction containing P120L. The branch
(lanes 3±6) P120 pre-mRNA was performed in U2-blocked extracts point was determined by primer extension on the lariat intermediate
not containing (lanes 1, 3, and 5) or containing (lanes 2, 4, and 6) using P107 as primer (lane 6). The 59 cleavage site was determined
an additional 29-O-methyl oligonucleotide, U1211±28, for 4 hr. RNAs by primer extension on the lariat intron using P110 as primer (lane
recovered from splicing reactions containing the 39-end-labeled 12). Dideoxy sequencing reactions used P107 (lanes 1±5) or P110
P120 substrate were aliquoted into two fractions:one was incubated (lanes 7±11) as primer.
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Figure 3. U12 snRNA Base Pairs with the
Conserved Branch Site Sequence of the P120
Intron
(A) Splicing reactions were performed in a
U2-blocked nuclear extract as in Figure 2 for
15 min. AMT psoralen was added and irradia-
tion with 365 nm light was carried out on ice
for 10 min. Recovered RNAs were aliquoted
into six fractions, followed by addition of
RNase H alone (lane 2) or RNase H plus 1 mg
U279±98 (lane 3), U164±75 (lane 4), 10L (anti-U11;
lane 5) or 9C (anti-U12; lane 6). The P120L
substrate (sub), two U12/pre-mRNA cross-
linked species (U12x1 and U12x2) and an as-
yet-unidentified cross-linked band (udx) are
indicated on the left.
(B) U12x1, U12x2, and comigrating RNAs
from a reaction not containing substrate were
gel purified. Primer extension blockage using
oligonucleotide P118 as primer was per-
formed on gel-purified RNAs (lanes 6±9) or
on total RNA isolated from a splicing reaction
without (lane 10) or with (lane 11) UV irradia-
tion. The same primer was used in dideoxy
sequencing reactions (lanes 1±5).
(C) The cross-linked sites of U12x1, U12x2,
and their comigrating RNAs were mapped on
U12 snRNA using oligonucleotide 9P as
primer (lanes 6±9). Dideoxy sequencing reac-
tions also used oligonucleotide 9P as primer
and HeLa nuclear RNA as template (lanes 1±
5). Note that the stop at G32 for U12x1 (lane
7) also appears in lane 1 and therefore may
result from aborted extension or a possible
additional cross-link at C31 (not shown here
nor in D and E).
(D) Potential base-pairs between the 39 con-
served element of the P120 intron and U12
snRNA are indicated by straight lines, with
cross-links indicated by lightning bolts. The
branch point adenosine is illustrated as
bulged from the U12/pre-mRNA helix.
(E) Cross-linked nucleotides of human U12
snRNA (Tarn et al., 1995) identified for U12x1
and U12x2 are indicated. The Sm site is
shaded.
is adjacent to the predicted intron branch site (lanes 7 Figure 3D. These results indicate that the U12 snRNP
interacts with the branch site of AT±AC introns and exe-and 9).
To determine cross-linked positions on U12 snRNA, cutes a function homologous to that characterized for
the U2 snRNP in the splicing of major class introns inan oligonucleotide complementary to nt 122±147 was
used as primer. In the major U12 cross-link, U12x1 (Fig- pre-mRNAs.
ure 3C, lane 7), stops were observed downstream of
A24, A25, and U28, adjacent to the predicted branch site Assembly of Splicing Complexes
on the P120 Pre-mRNApairing sequence (Figures 3D and 3E). The unusual
cross-linking of A nucleotides, previously observed in Complexes assembled on the AT±AC intron were exam-
ined by incubating the P120 pre-mRNA in U2-inactivatedtRNA (reviewed in Cimino et al., 1985), was confirmed
by primer extension blockage using another oligonucle- nuclear extract for various times, quenching with 0.25
mg/ml heparin, and electrophoresis on native polyacryl-otide, U1253±71, as primer (data not shown). Analysis of
the minor U12 cross-link, U12x2, showed a primary stop amide gels (Figure 4A, lanes 5±13). Splicing reactions
containing an adenovirus pre-mRNA substrate wereprior to nucleotide C61 in the third loop of U12 snRNA
(Figure 3C, lane 9, and Figure 3E). Additional studies fractionated in parallel (lanes 1±4) to compare the mobil-
ity and kinetics of appearance of splicing complexeswill be required to determine whether or not the U12x2
cross-link derives from a functional U12±branch site in- assembled on a major class versus an AT±AC intron.
With the P120 pre-mRNA, no specific complexes ex-teraction.
Deduced base-pairing interactions adjacent to the cept for a highly retarded band labeled ¥ were observed
in the absence of ATP (Figure 4A, lane 5). In addition tomajor cross-linked nucleotides in U12 snRNA and the
branch site sequence of the P120 intron are shown in band ¥, specific complexes A-1 and A-2 appeared under
A Novel Spliceosome Excises an AT±AC Intron
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the time of appearance of intermediates and products
in the splicing reaction (Figure 2A) correlates well with
the formation of complex C in Figure 4A, arguing that
complex C represents the catalytic spliceosome. The
slow kinetics of formation of P120 splicing complexes
suggest that some of the multiple factors that assemble
on the P120 pre-mRNA may be even more limiting in the
nuclear extract than those assembling onthe adenovirus
substrate.
The snRNP Content of AT±AC Splicing Complexes
snRNPs present in splicing complexes assembled on
the P120 pre-mRNA were next examined. Splicing reac-
tions containing optimal concentrations of nonradioac-
tive substrate (20 nM P120 versus 75 nM adenovirus)
were separated on nondenaturing polyacrylamide gels
as in Figure 4A, followed by Northern blot analyses (Fig-
Figure 4. Native Gel Electrophoresis of Splicing Complexes
ure 5). U12 snRNA was readily detected in all specific
(A) Splicing reactions using adenovirus substrate were carried out
complexes (A-1, A-2, B, and C) assembled on the P120in untreated nuclear extracts in the absence (lane 1) or presence
intron (lanes 7±14). The reaction lacking ATP also(lanes 2±4) of ATP for various times (min9) as indicated at the top (40
showed U12 comigrating with A-1 and A-2 (lane 15),min for the minus ATP reaction). Splicing reactions using uniformly
labeled P120 substrate were performed in U2-blocked (1.2 mM U2b) perhaps because of residual ATP in the extract or rep-
nuclear extracts in the absence (lane 5) or presence (lanes 6±13) of resenting an ATP-independent binding of U12 to the
ATP for the indicated times (min9 or hr) (4 hr for the minus ATP pre-mRNA.
reaction). Complexes H, A, B, and C assembled on the adenovirus
Hybridization with a U11 snRNA probe gave a signal,substrate are labeled on the left. Complexes H, A-1, A-2, B, and C
albeit faint, in complex A-1, but not in any of the otherassembled on the P120 substrate and an unidentified band (¥) are
splicing complexes (lanes 17±21); reactivity near the bot-indicated on the right.
(B) A splicing reaction containing uniformly labeled P120 substrate tom of the gel represents a U11 snRNP complex not
was performed in U2b-treated extract for 4 hr. Complexes were containing U12 (compareto lanes 4±15). When the hepa-
fractionated on a native gel as shown in (A). RNAs recovered from rin concentration was increased to 1 mg/ml, no signifi-
complexes C and B, respectively, were fractionated on a denaturing cant signal whatsoever was observed with the U11
polyacrylamide gel (lanes 2 and 3). Lane 1 shows an aliquot of the
probe and U12 snRNA was detected in complexes A-2,reaction before fractionation on the native gel.
B, and C, butnot in the position of complex A-1 (data not
shown). We hypothesize that complex A-1 is a functional
pre-spliceosome containing both the U11 and U12splicing conditions after 10 min (lane 6). Complex A-1,
which comigrates with complex A assembled on the snRNPs, and that heparin treatment strips the U11
snRNP from complex A-1, reducing it to complex A-2.adenovirus substrate (lanes 2±4), disappeared when the
heparin concentration was increased to 1 mg/ml (data Accordingly, affinity chromatography examining associ-
ation of snRNPs with the P120 pre-mRNA showed ap-not shown), whereas complex A-2 was more resistant
to heparin. Because both A-1 and A-2 complexes have proximately equal signals for U11 and U12 snRNPs at
both early (30 min) and later (4 hr) times in the splicingidentical kinetics of appearance, it seems likely that
complex A-2 is a heparin-generated breakdown product reaction (data not shown). These results hint that the
U11 snRNP is present not only in presplicing complexof complex A-1 (see below). The nature of band ¥ re-
mains obscure, since it does not hybridize to any anti- A but also in the functional spliceosome.
The U2 probe reacted with complexes assembled onsnRNA probes (see below) and appears in reactions
lacking ATP or functional U12 snRNPs (lane 5 and data the adenovirus pre-mRNA (lane 22), but not on the P120
pre-mRNA (lanes 23±27). This confirms our earlier indi-not shown). Complex B was observed after 40 min of
incubation and continued to accumulate at later times cations (Figures 1±3) that the U12 snRNP, but not the
U2 snRNP, is a component of the spliceosome that cata-(lanes 8±13), whereas the level of complexes A-1 and
A-2 and nonspecific complex H declined as complex B lyzes excision of AT±AC introns.
Hybridization with anti-sense U5, U4, and U6 RNAincreased. After 1 hr of incubation, the slowest migrating
complex C appeared and accumulated (lanes 9±13). probes (lanes 28±51) detected all three snRNAs in splic-
ing complexes Band C assembled onthe control adeno-Complexes B and C assembled on the P120 pre-mRNA
have electrophoretic mobilities similar to complexes B virus substrate (lanes 29, 40, and 46); the smear near
the bottom of the gel presumably corresponds to theand C previously characterized for the adenovirus sub-
strate (Konarska, 1990). U5±U4/U6 tri-snRNP in the nuclear extract (lanes 28±51).
Surprisingly, only the U5 probe yielded a distinct signalAnalysis of radioactive RNAs recovered from com-
plexes A-1, A-2, and B formed on the P120 substrate in complex B (and perhaps also in complex C) assem-
bled on the P120 pre-mRNA (compare lanes 33±38 withrevealed only unspliced precursor and a few degraded
fragments (Figure 4B, lane 3, and data not shown). Com- 41±45 [anti-U4] and 47±51 [anti-U6]). snRNP aggregates
appeared in many of the wells of the gel whether or notplex C contained splicing intermediates and products,
as well as precursor RNA (Figure 4B, lane 2). Indeed, the reactions contained splicing substrates and may be
Cell
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Figure 6. Effects of 29-O-methyl Oligonucleotides on Splicing
Splicing reactions were carried out in nuclear extracts using adeno-
virus pre-mRNA substrate for 1.5 hr in the absence (lane 1) or pres-
ence (lanes 2±10) of 29-O-methyl oligonucleotides as follows: 15 mM
U11±14 (lane 2); 4 mM U2b (lane 3); 15 mM U111±20 (lane 4); 0.5 mM
U1211±28 (lane 5); 15, 10, or 5 mM U5L (lanes 6±8), 15 or 5 mM U627±45
(lanes 9±10). Uniformly labeled (lanes 11±15) or 39-end labeled (lanes
16±20) P120 substrate was incubated in splicing reactions for 4 hr
in the presence of the 29-O-methyl oligonucleotide U2b (at 1.2 mM)
alone (lanes 11 and 16) or U2b plus an additional oligonucleotide
as follows: 0.5 mM U1211±28 (lane 12); 15 mM U111±20 (lane 13); 15 or
5 mM U627±45 (lanes 14±15); 2, 5, 10, or 15 mM U5L (lanes 17±20).
Symbols are as in Figure 2A. Asterisks represent degraded P120
substrate fragments. Note that lane 1 was underloaded.Figure 5. Northern Blot Analyses of Splicing Complexes
Splicing reactions were performed in untreated nuclear extract for
20 min in the absence (lane 4) or presence (lane 5) of adenovirus
pre-mRNA, or in a U2-blocked (1.2 mM U2b) extract for the indicated adenovirus substrate was inhibited by 29-O-methyl oli-
times (min9 or hr) in the absence (lane 6) or presence (lanes 7±15) gonucleotides U11±14 and U2b at concentrations of 15
of P120 pre-mRNA. ATP was not included in lane 15; 4 hr incubations and 4 mM, respectively, whereas oligonucleotides com-
were performed for the minus substrate (lane 6) and minus ATP
plementary to nt 1±20 of U11 or 11±28 of U12 had no(lane 15) reactions. Complexes were separated on a native gel and
effect (lanes 1±5). With the P120 pre-mRNA, titration oftransferred onto a nylon membrane. The blot was successively hy-
U11±14 at 5±15 mM or U2b at 0.4±4 mM instead increasedbridized with the following probes: anti-U12 (lanes 4±15; 20-hr expo-
sure), -U2 (lanes 22±27; 5 hr), -U6 (lanes 46±51; 20 hr), -U5 (lanes correct splicing (Figure 1 and data not shown). In con-
28±39; 12 hr), -U4 (lanes 40±45; 20 hr), -U559±117 (data not shown), trast, the 29-O-methyl oligonucleotide U1211±28, which se-
and -U11 (lanes 16±21; 40 hr). Selected lanes are shown for the anti- questers the branch site pairing sequence of U12, effec-
U11, -U2, -U4 and -U6 hybridized blots. Lanes 1±3 show splicing
tively blocked splicing of the P120 substrate (lane 12;reactions containing 32P-labeled P120 substrate carried out in U2b-
97% inhibition), confirming data shown in Figure 2B.treated extract for various times. The identities of P120 complexes
Because the 59 end of U11 snRNA has been proposedas determined in Figure 4 are indicated at the left.
to pair with the 59 splice site of AT±AC introns (Hall and
Padgett, 1994), a 29-O-methyl oligonucleotide designed
to sequester its first 20 nucleotides was titrated into theespecially prominent because of the high concentration
extract. No effect on the splicing of the P120 pre-mRNAof extract used in our splicing reactions (see Experimen-
was detected even at an oligonucleotide concentrationtal Procedures).
of 15 mM (3000-fold more than the calculated concentra-We conclude that the U11 and U12 snRNPs initially
tion of U11 snRNPs in the extract; lane 13). The bindingand the U5 snRNP subsequently assemble on the P120
of a biotinylated oligonucleotide complementary to apre-mRNA. Both the U12 and U5 snRNPs remain stably
similar region of U11 snRNA had been assessed pre-associated during splicing of the AT±AC intron.
viously; the selection of only 15% of the U11 snRNPs
in nuclear extract suggested limited accessibility of this
region (Wassarman and Steitz, 1992). At present,P120 Splicing Is Inhibited by Blocking
the U12 and U5 snRNPs whether U11 directly contacts the P120 pre-mRNA is
not clear.We next investigated whether the snRNPs identified in
association with the P120 pre-mRNA are essential com- Although there exist at least seven U5 variants in HeLa
cells, all contain an invariant 9 nt sequence in their firstponents of the AT±AC spliceosome by using
29-O-methyl oligonucleotides complementary to various loop (Sontheimer and Steitz, 1992) that is implicated in
exon interactions during splicing of major class intronssnRNAs (Figure 6). As expected, splicing of the control
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(Newman and Norman, 1992; Wyatt et al., 1992; Son-
theimer and Steitz, 1993). When a 29-O-methyl oligonu-
cleotide (also containing 2,6-diaminopurine; Lamm et
al., 1991) complementary to loop 1 of U5 was used to
pretreat nuclear extracts, inhibition of adenovirus splic-
ing resulted (lanes 6±8), as expected. Lanes 16±20 show
that P120 splicing likewise became inactivated with in-
creasing amounts of the U5L oligonucleotide (94% inhi-
bition at 15 mM U5L). For unknown reasons, high con-
centrations of U5L markedly enhanced degradation of
the P120 pre-mRNA; therefore, 39-end-labeled rather
than uniformly labeled P120 substrate was used for this
experiment and electrophoresis was carried out for
twice as long as usual to resolve the spliced product and
lariat intermediate from prominent degraded fragments
(asterisk and double asterisk; lanes 16±20). U5 participa-
tion in P120 splicing was confirmed by the observation
Figure 7. Schematic Pathway of Splicing Complex Assemblythat formation of complexes B and C on the P120 sub-
The left diagram shows splicing complexes assembled on a pre-strate was impaired by pretreatment of the splicing ex-
mRNA containing a major class intron, modified from Moore et al.tract with 10±15 mM U5L; control experiments also ruled
(1993). U1 binds to the 59 splice site, together with non-snRNP
out specific degradation of splicing product and lariat factors (not shown here), to form a commitment complex (CC). U2
intermediate by the U5L oligonucleotide (data not subsequently binds to the branch site to form presplicing complex
shown). Note that the concentrations of U5L required A. Complex B is formed by recruiting the U5-U4/U6 tri-snRNP into
the spliceosome. The right diagram shows assembly of splicingto inactivate splicing of the adenovirus and P120 sub-
complexes on an AT±AC intron. Association of U11, U12, and U5strates are similar (lanes 6±8 and 17±20), arguing that
snRNPs with the pre-mRNA was observed by native gel electropho-the same conserved 9 nt loop sequence is shared by
resis. The pre-spliceosome, complex A, contains both U11 and U12
the U5 variant(s) involved in P120 splicing and those in snRNPs; the binding of U12 to the intron branch site was demon-
the major spliceosome (Sontheimer and Steitz, 1992). strated by psoralen cross-linking. Complexes A-1 and A-2 are not
Finally, 29-O-methyl oligonucleotides complementary discriminated here but are discussed in the text. The U5 snRNP
then joins the prespliceosome to form complex B, which may containto U4 and U6 snRNAs were evaluated for their effect on
other as-yet-unidentified snRNPs. Whether the 59 splice site is rec-P120 pre-mRNA splicing. In control experiments, splic-
ognized by U11 and whether U5 associates with other snRNP(s)ing of the adenovirus substrate was completely abol-
before entering the splicing complex remain to be established.
ished by oligonucleotide U627±46, which masks the phylo-
genetically conserved ACAGAG box and its upstream
AT±AC introns follows a two-step pathway akin to thatregion in U6 snRNA (lanes 9±10). Strikingly, splicing of
characterized for self-splicing of group II introns and forthe P120 pre-mRNA in the U627±46-pretreated extract was
splicing of the major class of pre-mRNA introns. Finally,not diminished (lanes 14±15). This result is consistent
we show that the AT±AC spliceosome contains threewith the lack of detectable U6 in Northern blot analyses
known Sm snRNPs (U5, U11, and U12) and demonstrateof splicing complexes formed on the P120 substrate
that two of these (U5 and U12) are essential for the(Figure 5), but alternative explanations are possible (see
splicing reaction.Discussion). Unfortunately, under our splicing condi-
In Figure 7, a proposed pathway for assembly of thetions, a 29-O-methyl oligonucleotide complementary to
AT±AC spliceosome is compared with that of the well-nt 1±20 of U4 snRNA did not inhibit adenovirus splicing
studied spliceosome formed on the majority of pre-as previously reported (Blencowe et al., 1989). Hence,
mRNA introns. Under splicing conditions, the U11 andthe negative result we obtained with this oligonucleotide
U12 snRNPs associate with the precursor RNA to formfor the P120 pre-mRNA (data not shown) cannot be
a presplicing complex, detected by both native gel elec-interpreted.
trophoresis (Figure 5) and affinity chromatography (data
not shown). The binding of the U12 snRNP involves
a base-pairing interaction with the intron branch site,Discussion
yielding a diagnostic psoralen cross-link. Presplicing
complexes A-1 and A-2 are distinguished by the pres-An active in vitro system for the splicing of a pre-mRNA
containing an AT±AC intron has provided the first mech- ence of the U11 snRNP: U11 appears only in the A-1
complex on native gels, suggesting that complex A-2anistic insights into the functioning of a novel minor
spliceosome present in vertebrate (and perhaps all results from stripping of the U11 snRNP by heparin.
The U5 snRNP subsequently joins complex A to form ametazoan) cells. We have established that the low abun-
dance U12 snRNP and the U2 snRNP act analogously slower migrating complex B, whose mobility hints that
other as-yet-unidentified snRNPsmay be present. Com-with respect tobranch site recognition in their respective
spliceosomes. Additionally, we have characterized a plex B then undergoes conversion to the catalytically
active C complex, which generates splicing intermedi-splicing intermediate, the intron±39 exon, as a lariat
structure in which an adenosine within the conserved ates and products (not shown in Figure 7). The parallels
with the major spliceosome are striking, but much re-element upstream of the 39 splice site serves as the
branch point, forming an A±A linkage. Thus, excision of mains to be learned about the AT±AC spliceosome.
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The U12 snRNP Replaces U2 an snRNP that functions analogously to U6 (Konforti
et al., 1993; Crispino and Sharp, 1995) to the AT±ACin the AT±AC Spliceosome
Accurate splicing of the P120 pre-mRNA was activated spliceosome. Whereas the 59 splice site of major class
introns is sequentially recognized by SR proteins, U1by debilitating either the U2 snRNP (Figure 1) or the
U1 snRNP (data not shown) in vitro, suggesting that and U6 snRNPs (Kandels-Lewis and Seraphin, 1993;
Konforti et al., 1993; Lesser and Guthrie, 1993; Kohtz etformation of the major spliceosome effectively com-
petes with the binding of low abundance snRNPs to this al., 1994), AT±AC introns may bypass this sequential
recognition mechanism by containing a stretch of abso-particular AT±AC intron. Indeed, when the U2 snRNP
remained unblocked in the extract, aberrant splicing at lutely conserved nucleotides at the 59 splice site (Hall
and Padgett, 1994). The 59 end of the intron could becryptic sites that are close to the authentic AT±AC splice
sites (Figure 1) and cross-linking of U2 snRNA to the defined by the U5 snRNP alone, just as U5 interactions
can determine the 59 cleavage site in major class intronsP120 pre-mRNA (data not shown) were observed. Al-
though we do not yet know whether such cryptic splicing under special circumstances (Newman and Norman,
1992; Cortes et al., 1993). Or, a U6 analog could becharacterizes all AT±AC introns, how the low abundance
U11 and U12 snRNPs manage to associate competi- recruited directly to the 59 splice site. Previously, we
showed that splicing of the adenovirus pre-mRNA couldtively with U1 and U2 on the P120 intron in vivo remains
mysterious. be reactivated by excess amounts of SR proteins in
nuclear extracts pretreated with a 29-O-methyl oligonu-Our cross-linking evidence argues that U12 snRNA,
like U2, base-pairs with a conserved sequence near cleotide U11±14 (Tarn and Steitz, 1994), suggesting direct
U6 binding. In contrast, proper splicing of the P120 pre-the 39 end of the P120 intron, probably bulging out an
adenosine from the intermolecular helix (Figure 3). Ac- mRNA in U1- or U2-debilitated extracts does not require
excess SR proteins; supplementation of U2-blockedcordingly, sequestering the recognition sequence in U12
snRNA with a 29-O-methyl oligonucleotide blocks forma- S100 extract with SR proteins showed that endogenous
levels of SR proteins are essential (Tarn and Steitz, un-tion of both U12/pre-mRNA cross-links (see Figure 3),
as well as the appearance of splicing complexes, inter- published data). This indicates that at least some SR
proteins are shared by themajor and the AT±AC spliceo-mediates, and products (Figures 2 and 6 and data not
shown). Very recently, Hall and Padgett (1996) have some and could contribute to 59 splice site recognition
in AT±AC introns.demonstrated a requirement for U12 snRNA in in vivo
splicing of an AT±AC intron by showing that mutations
in the conserved 39 element of the P120 intron can be
U5: a Common Component of Two Kindssuppressed by compensatory changes in the predicted
of Spliceosomesbranch site pairing sequence of U12 snRNA. Leaving an
Our results implicate a U5 snRNP in the splicing of theadenosine unpaired for nucleophilic attack is a mecha-
P120 pre-mRNA (Figures 5 and 6). Seven characterizednism similar to that established for the self-splicing of
U5 variants can be detected in affinity-purified spliceo-group II introns and for spliceosome-mediated removal
somes assembled on a major class intron (Sontheimerof the major class of introns from nuclear pre-mRNAs.
and Steitz, 1992); it is not yet known which one (or more)Thus, U12 snRNA, like U2 snRNA and sequences within
of these, or even an as-yet-unidentified U5 variant, isdomain VI of group II introns, is a likely contributor to
used by an AT±AC intron. Rehybridization of a Northernactivation of the branch site 29-OH group during the first
blot containing P120 splicing complexes with an anti-step of splicing.
sense U5 probe lacking the invariant loop 1 sequence
(data not shown) argues against the possibility that only
this conserved sequence, imbedded in a novel snRNA,What Recognizes the 59 Splice Site?
We have not been able toconfirm a base-pairing interac- was detected in Figure 5.
Why is U5 apparently the only snRNP that is sharedtion between the 59 splice site of the AT±AC intron and
the 59 end of U11 snRNA, as proposed by Hall and by two different kinds of spliceosomes? Both genetic
(Newman and Norman, 1992) and site-specific cross-Padgett (1994). First, a 29-O-methyl oligonucleotide
complementary to the 59 end of U11 RNA did not inhibit linking (Wyatt et al., 1992; Sontheimer and Steitz, 1993)
studies have revealed intimate contacts of the invariantsplicing of the P120 substrate (Figure 6). Second, even
though an ideal cross-linking site with U11 is predicted first loop of U5 RNA with both the 59 and 39 exons during
the splicing reaction. Thus, this U5 loop hasbeen viewednear the 59 end of the P120 intron, an unidentified pso-
ralen cross-linked species could not be targeted by as the spliceosomal counterpart of the internal guide
sequence of self-splicing group I introns and of the exonRNase H in the presence of two different U11 oligonucle-
otides (Figure 3 and data not shown). Nonetheless, binding site 1 of group II introns (Sontheimer and Steitz,
1993, references therein); its U-rich character has beenU11's structural similarities to U1 (Montzka and Steitz,
1988), as well as its association with U12 (Wassarman hypothesized to confer extensive flexibility in interacting
with divergent exon sequences. The highly conservedand Steitz, 1992) and with the pre-mRNA during splicing
(Figure 5), suggest an active role for the U11 snRNP in very large U5 snRNP protein, p220, may stabilize or act
to facilitate these interactions (Wyatt et al., 1992). U5splice site selection or in assisting U12 association, as
characterized for the U1 snRNP in addition to its base- is not known to be involved in specific base-pairing
interactions with any other spliceosomal snRNP andpairing function (Tarn and Steitz, 1995).
An alternative possibility is that a splicing component may therefore be uniquely suited to join a distinct set
of snRNPs in the low abundance AT±AC spliceosome.other than U11 recognizes the 59 splice site and recruits
A Novel Spliceosome Excises an AT±AC Intron
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Definitive analysis of the U5 sequence(s) present in the contrast to the major class of introns, the region between
the branch site and the 39 splice site of AT±AC intronsAT±AC spliceosome is now required.
is relatively short (9±12 nt) and lacks a long pyrimidine
stretch. This and thehigh conservation of the branch siteWhat Substitutes for U4 and U6
sequence suggest that binding by non-snRNP proteinsin the AT±AC Spliceosome?
(such as U2 auxiliary factor) to the region between theU6, the most conserved spliceosomal snRNA, plays crit-
branch point and the 39 splice site (reviewed in Lammical roles in pre-mRNA splicing, including proofreading
and Lamond, 1993) may not be required for splicing ofof the 59 splice site (Kandels-Lewis and Seraphin, 1993;
AT±AC introns. But, if the orderly assembly of spliceo-Lesser and Guthrie, 1993) and possibly catalysis of the
somes on a multi-intron pre-mRNA is achieved by U1/splicing reaction itself (reviewed in Guthrie, 1991;
U2 contacts across exons (reviewed in Berget, 1995),Weiner, 1993). In the major class spliceosome, U6 en-
can U1 communicate with U12 and U11 with U2 as well?gages in several distinct base-pairing interactions with
Previously, Gontarek et al. (1993) proposed a role forU2, which serve to juxtapose the two reactants (the 59
the U11/U12 snRNP in negative control of splicing of ansplice site and the bulged branch nucleotide) prior to
NRS (negative regulator of splicing)-containing intron.the first covalent reaction (Madhani and Guthrie, 1992;
The NRS within the gag gene of RSV modulates the ratioSun and Manley, 1995). Two alternative U2/U6 struc-
of unspliced to spliced retroviral RNA. Although a base-tures, similar either to domain V of group II introns or to
pairing interaction between loop 3 of U11 snRNA anda hairpin ribozyme, have been postulated. We previously
the NRS was suggested, exactly how binding of the U11/pointed out that U12 snRNA might be able to substitute
U12 snRNP might inhibit splicing of the NRS-containingfor U2 in each of these RNA±RNA interactions with U6
pre-mRNA remained unclear. Perhaps, the U11/U12(Tarn et al., 1995); however, our current results from
snRNP plays opposing roles in the removal of majorNorthern blot analyses (Figure 5) and splicing inhibition
class versus AT±AC introns from pre-mRNAs.experiments (Figure 6) do not support this proposal.
The few genes known to contain an AT±AC intronFailure to detect U6 snRNA in the P120 spliceosome by
appear to be quite diverse; however, commonalities mayNorthern blot analysis could be due to sequestration of
emerge as more AT±AC introns are identified. PerhapsU6 sequences by other splicing components. Yet, the
the discovery of additional AT±AC introns will reveal aapparent absence of U4 as well argues that this well-
tissue specificity or other regulatory role for this novelcharacterized two-snRNP complex may not participate
intron class. The distinctive components of the AT±ACin the removal of AT±AC introns from nuclear pre-
spliceosome, the U11 and U12 snRNPs, need to bemRNAs.
investigated for their relative abundance in various tis-If the U4/U6 snRNP is not essential for splicing of
sues and their presence in otherspecies. The fundamen-the P120 pre-mRNA, what snRNP(s) or protein factor(s)
tal question of why metazoan cells maintain a second,substitute? And, does it (they) preassociate with the U5
low abundance pre-mRNA splicing machinery providessnRNP to form a multi-snRNP particle prior to AT±AC
an impetus for many future studies of the AT±ACspliceosome assembly? We have investigated the pos-
spliceosome.sible participation of the 7SK snRNP, whose RNA (like
U6) is g-methyl capped and highly conserved, in P120
Experimental Procedures
splicing, but no positive evidence has emerged so far.
It will be interesting to examine whether one of the addi- Oligonucleotides
tional HeLa cell snRNAs precipitated with antibodies Both deoxyoligonucleotides and 29-O-methyl oligoribonucleotides
were synthesized by John Flory at Yale University on an Appliedagainst g-methyl guanosine is a U6 counterpart in the
Biosystems DNA synthesizer. The following 29-O-methyl oligoribo-AT±AC spliceosome (Gupta et al., 1990). Characteriza-
nucleotides were used for pretreatment of nuclear extracts: U11±14;tion of such an RNA will provide important new informa-
U2b, complementary to nt 27±49 of U2 snRNA (both described by
tion to test and hone current ideas (Weiner, 1993) con- Tarn and Steitz, 1994); U5L (59-UUZGUZZZZGGCGAAA-39; Z repre-
cerning the functional relationship between U6 snRNA sents diaminopurine), complementary to nt 33±48 of U5 snRNA;
and domain V (the most highly conserved) of group II U627±46 (59-CUCUGUAUCGUUCCAAUUUU-39); U111±20 (59-UCACGAC
AGAAGCCCUUUUU-39); and U1211±28 (59-AUUUUCCUUACUCAUself-splicing introns.
AAG-39). Biotinylated 29-O-methyl oligoribonucleotide P120bio (59-
BBBBGCUUGCCAAGCAGGAAGUCUCC-39; B represents biotin),
Other Questions Raised by the complementary to nt 153±174 of exon 2 of the P120L pre-mRNA
substrate, was used for affinity selection of splicing complexes.AT±AC Spliceosome
Deoxyoligonucleotides used for primer extension were P107 (59-Presently, it appears that only a few splicing compo-
CAGAACGAGACCGCCCTTCC-39), complementary to nt 86±105 ofnents are shared by the major and minor class human
the 39 exon of P120L; P110 (59-ACTGTGTCATGATGTCCTAA-39),
spliceosomes. These include the U5 snRNP, the Sm complementary to nt 64±83 of the P120 intron; P118 (59-CCCACAAT
(core) proteins of the U11 and U12 snRNPs, and some ATCCTGGATCCG-39), complementary to nt 36±55 of the 39 exon of
member(s) of the SR protein family. It is not clear if the P120; and9P, complementary to nt 122±147 of U12 snRNA (Montzka
and Steitz, 1988). Antisense deoxyoligonucleotides used for RNaseU11 particle contains any U1-specific proteins or if U12
H cleavage were U164±75, U279±98 (both described by Tarn and Steitz,associates with polypeptides specific to the 17S U2
1994), 10L and 9C, complementary to nt 52±71 of U11 and 53±71snRNP (reviewed in Hodges and Beggs, 1994). Although
of U12 snRNAs, respectively (Montzka and Steitz, 1988).
two proteins that seem to be unique to the U11 snRNP
have been identified as targets of rare autoantibodies Plasmid Construction
(Gilliam and Steitz, 1993), whether they are associated For construction of pP120L, a PCR-amplified DNA fragment was
first generated using pCB6P120m (a gift from Richard Padgett,with the AT±AC spliceosome remains to be seen. In
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Cleveland Clinic) as template; this fragment containing the T7 pro- was stripped by incubation in 0.1 3 SSC plus 0.5% SDS at 958C
for 15 min.moter and the entire sequence of exon 6-intron F-exon 7 of the
human P120 gene (Larson et al., 1990; Hall and Padgett, 1994)
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